Global Graves Disease Treatment Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
LPI (LP Information)' newest research report, the “Graves Disease Treatment Industry Forecast” looks at past sales and reviews total world Graves Disease Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Graves Disease Treatment sales for 2023 through 2029. With Graves Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Graves Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Graves Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Graves Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Graves Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Graves Disease Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Graves Disease Treatment.
The global Graves Disease Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Graves Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Graves Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Graves Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Graves Disease Treatment players cover Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Graves Disease Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Graves Disease Treatment market?
What factors are driving Graves Disease Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Graves Disease Treatment market opportunities vary by end market size?
How does Graves Disease Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
LPI (LP Information)' newest research report, the “Graves Disease Treatment Industry Forecast” looks at past sales and reviews total world Graves Disease Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Graves Disease Treatment sales for 2023 through 2029. With Graves Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Graves Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Graves Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Graves Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Graves Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Graves Disease Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Graves Disease Treatment.
The global Graves Disease Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Graves Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Graves Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Graves Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Graves Disease Treatment players cover Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Graves Disease Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Anti-Thyroid Medication
- Radioactive Iodine Therapy
- Hospitals Pharmacies
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- GlaxoSmithKline plc
- Merck & Co
- Pfizer, Inc
- RLC LABS
- AbbVie, Inc
- Mylan N.V
- Allergan, plc
- Novartis AG
- Apitope
- Amgen INC.
- Sun Pharmaceuticals Industries LTD
- Immunovant Inc
What is the 10-year outlook for the global Graves Disease Treatment market?
What factors are driving Graves Disease Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Graves Disease Treatment market opportunities vary by end market size?
How does Graves Disease Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Graves Disease Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Graves Disease Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Graves Disease Treatment by Country/Region, 2018, 2022 & 2029
2.2 Graves Disease Treatment Segment by Type
2.2.1 Anti-Thyroid Medication
2.2.2 Radioactive Iodine Therapy
2.3 Graves Disease Treatment Sales by Type
2.3.1 Global Graves Disease Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Graves Disease Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Graves Disease Treatment Sale Price by Type (2018-2023)
2.4 Graves Disease Treatment Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.5 Graves Disease Treatment Sales by Application
2.5.1 Global Graves Disease Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Graves Disease Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Graves Disease Treatment Sale Price by Application (2018-2023)
3 GLOBAL GRAVES DISEASE TREATMENT BY COMPANY
3.1 Global Graves Disease Treatment Breakdown Data by Company
3.1.1 Global Graves Disease Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Graves Disease Treatment Sales Market Share by Company (2018-2023)
3.2 Global Graves Disease Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Graves Disease Treatment Revenue by Company (2018-2023)
3.2.2 Global Graves Disease Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Graves Disease Treatment Sale Price by Company
3.4 Key Manufacturers Graves Disease Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Graves Disease Treatment Product Location Distribution
3.4.2 Players Graves Disease Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GRAVES DISEASE TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Graves Disease Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Graves Disease Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Graves Disease Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Graves Disease Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Graves Disease Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Graves Disease Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Graves Disease Treatment Sales Growth
4.4 APAC Graves Disease Treatment Sales Growth
4.5 Europe Graves Disease Treatment Sales Growth
4.6 Middle East & Africa Graves Disease Treatment Sales Growth
5 AMERICAS
5.1 Americas Graves Disease Treatment Sales by Country
5.1.1 Americas Graves Disease Treatment Sales by Country (2018-2023)
5.1.2 Americas Graves Disease Treatment Revenue by Country (2018-2023)
5.2 Americas Graves Disease Treatment Sales by Type
5.3 Americas Graves Disease Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Graves Disease Treatment Sales by Region
6.1.1 APAC Graves Disease Treatment Sales by Region (2018-2023)
6.1.2 APAC Graves Disease Treatment Revenue by Region (2018-2023)
6.2 APAC Graves Disease Treatment Sales by Type
6.3 APAC Graves Disease Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Graves Disease Treatment by Country
7.1.1 Europe Graves Disease Treatment Sales by Country (2018-2023)
7.1.2 Europe Graves Disease Treatment Revenue by Country (2018-2023)
7.2 Europe Graves Disease Treatment Sales by Type
7.3 Europe Graves Disease Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Graves Disease Treatment by Country
8.1.1 Middle East & Africa Graves Disease Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Graves Disease Treatment Sales by Type
8.3 Middle East & Africa Graves Disease Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Graves Disease Treatment
10.3 Manufacturing Process Analysis of Graves Disease Treatment
10.4 Industry Chain Structure of Graves Disease Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Graves Disease Treatment Distributors
11.3 Graves Disease Treatment Customer
12 WORLD FORECAST REVIEW FOR GRAVES DISEASE TREATMENT BY GEOGRAPHIC REGION
12.1 Global Graves Disease Treatment Market Size Forecast by Region
12.1.1 Global Graves Disease Treatment Forecast by Region (2024-2029)
12.1.2 Global Graves Disease Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Graves Disease Treatment Forecast by Type
12.7 Global Graves Disease Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Graves Disease Treatment Product Portfolios and Specifications
13.1.3 Abbott Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 GlaxoSmithKline plc
13.2.1 GlaxoSmithKline plc Company Information
13.2.2 GlaxoSmithKline plc Graves Disease Treatment Product Portfolios and Specifications
13.2.3 GlaxoSmithKline plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline plc Main Business Overview
13.2.5 GlaxoSmithKline plc Latest Developments
13.3 Merck & Co
13.3.1 Merck & Co Company Information
13.3.2 Merck & Co Graves Disease Treatment Product Portfolios and Specifications
13.3.3 Merck & Co Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck & Co Main Business Overview
13.3.5 Merck & Co Latest Developments
13.4 Pfizer, Inc
13.4.1 Pfizer, Inc Company Information
13.4.2 Pfizer, Inc Graves Disease Treatment Product Portfolios and Specifications
13.4.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer, Inc Main Business Overview
13.4.5 Pfizer, Inc Latest Developments
13.5 RLC LABS
13.5.1 RLC LABS Company Information
13.5.2 RLC LABS Graves Disease Treatment Product Portfolios and Specifications
13.5.3 RLC LABS Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 RLC LABS Main Business Overview
13.5.5 RLC LABS Latest Developments
13.6 AbbVie, Inc
13.6.1 AbbVie, Inc Company Information
13.6.2 AbbVie, Inc Graves Disease Treatment Product Portfolios and Specifications
13.6.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AbbVie, Inc Main Business Overview
13.6.5 AbbVie, Inc Latest Developments
13.7 Mylan N.V
13.7.1 Mylan N.V Company Information
13.7.2 Mylan N.V Graves Disease Treatment Product Portfolios and Specifications
13.7.3 Mylan N.V Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mylan N.V Main Business Overview
13.7.5 Mylan N.V Latest Developments
13.8 Allergan, plc
13.8.1 Allergan, plc Company Information
13.8.2 Allergan, plc Graves Disease Treatment Product Portfolios and Specifications
13.8.3 Allergan, plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Allergan, plc Main Business Overview
13.8.5 Allergan, plc Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Graves Disease Treatment Product Portfolios and Specifications
13.9.3 Novartis AG Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Apitope
13.10.1 Apitope Company Information
13.10.2 Apitope Graves Disease Treatment Product Portfolios and Specifications
13.10.3 Apitope Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Apitope Main Business Overview
13.10.5 Apitope Latest Developments
13.11 Amgen INC.
13.11.1 Amgen INC. Company Information
13.11.2 Amgen INC. Graves Disease Treatment Product Portfolios and Specifications
13.11.3 Amgen INC. Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Amgen INC. Main Business Overview
13.11.5 Amgen INC. Latest Developments
13.12 Sun Pharmaceuticals Industries LTD
13.12.1 Sun Pharmaceuticals Industries LTD Company Information
13.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolios and Specifications
13.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sun Pharmaceuticals Industries LTD Main Business Overview
13.12.5 Sun Pharmaceuticals Industries LTD Latest Developments
13.13 Immunovant Inc
13.13.1 Immunovant Inc Company Information
13.13.2 Immunovant Inc Graves Disease Treatment Product Portfolios and Specifications
13.13.3 Immunovant Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Immunovant Inc Main Business Overview
13.13.5 Immunovant Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Graves Disease Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Graves Disease Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Graves Disease Treatment by Country/Region, 2018, 2022 & 2029
2.2 Graves Disease Treatment Segment by Type
2.2.1 Anti-Thyroid Medication
2.2.2 Radioactive Iodine Therapy
2.3 Graves Disease Treatment Sales by Type
2.3.1 Global Graves Disease Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Graves Disease Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Graves Disease Treatment Sale Price by Type (2018-2023)
2.4 Graves Disease Treatment Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.5 Graves Disease Treatment Sales by Application
2.5.1 Global Graves Disease Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Graves Disease Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Graves Disease Treatment Sale Price by Application (2018-2023)
3 GLOBAL GRAVES DISEASE TREATMENT BY COMPANY
3.1 Global Graves Disease Treatment Breakdown Data by Company
3.1.1 Global Graves Disease Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Graves Disease Treatment Sales Market Share by Company (2018-2023)
3.2 Global Graves Disease Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Graves Disease Treatment Revenue by Company (2018-2023)
3.2.2 Global Graves Disease Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Graves Disease Treatment Sale Price by Company
3.4 Key Manufacturers Graves Disease Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Graves Disease Treatment Product Location Distribution
3.4.2 Players Graves Disease Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GRAVES DISEASE TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Graves Disease Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Graves Disease Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Graves Disease Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Graves Disease Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Graves Disease Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Graves Disease Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Graves Disease Treatment Sales Growth
4.4 APAC Graves Disease Treatment Sales Growth
4.5 Europe Graves Disease Treatment Sales Growth
4.6 Middle East & Africa Graves Disease Treatment Sales Growth
5 AMERICAS
5.1 Americas Graves Disease Treatment Sales by Country
5.1.1 Americas Graves Disease Treatment Sales by Country (2018-2023)
5.1.2 Americas Graves Disease Treatment Revenue by Country (2018-2023)
5.2 Americas Graves Disease Treatment Sales by Type
5.3 Americas Graves Disease Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Graves Disease Treatment Sales by Region
6.1.1 APAC Graves Disease Treatment Sales by Region (2018-2023)
6.1.2 APAC Graves Disease Treatment Revenue by Region (2018-2023)
6.2 APAC Graves Disease Treatment Sales by Type
6.3 APAC Graves Disease Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Graves Disease Treatment by Country
7.1.1 Europe Graves Disease Treatment Sales by Country (2018-2023)
7.1.2 Europe Graves Disease Treatment Revenue by Country (2018-2023)
7.2 Europe Graves Disease Treatment Sales by Type
7.3 Europe Graves Disease Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Graves Disease Treatment by Country
8.1.1 Middle East & Africa Graves Disease Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Graves Disease Treatment Sales by Type
8.3 Middle East & Africa Graves Disease Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Graves Disease Treatment
10.3 Manufacturing Process Analysis of Graves Disease Treatment
10.4 Industry Chain Structure of Graves Disease Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Graves Disease Treatment Distributors
11.3 Graves Disease Treatment Customer
12 WORLD FORECAST REVIEW FOR GRAVES DISEASE TREATMENT BY GEOGRAPHIC REGION
12.1 Global Graves Disease Treatment Market Size Forecast by Region
12.1.1 Global Graves Disease Treatment Forecast by Region (2024-2029)
12.1.2 Global Graves Disease Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Graves Disease Treatment Forecast by Type
12.7 Global Graves Disease Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Graves Disease Treatment Product Portfolios and Specifications
13.1.3 Abbott Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 GlaxoSmithKline plc
13.2.1 GlaxoSmithKline plc Company Information
13.2.2 GlaxoSmithKline plc Graves Disease Treatment Product Portfolios and Specifications
13.2.3 GlaxoSmithKline plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline plc Main Business Overview
13.2.5 GlaxoSmithKline plc Latest Developments
13.3 Merck & Co
13.3.1 Merck & Co Company Information
13.3.2 Merck & Co Graves Disease Treatment Product Portfolios and Specifications
13.3.3 Merck & Co Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck & Co Main Business Overview
13.3.5 Merck & Co Latest Developments
13.4 Pfizer, Inc
13.4.1 Pfizer, Inc Company Information
13.4.2 Pfizer, Inc Graves Disease Treatment Product Portfolios and Specifications
13.4.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer, Inc Main Business Overview
13.4.5 Pfizer, Inc Latest Developments
13.5 RLC LABS
13.5.1 RLC LABS Company Information
13.5.2 RLC LABS Graves Disease Treatment Product Portfolios and Specifications
13.5.3 RLC LABS Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 RLC LABS Main Business Overview
13.5.5 RLC LABS Latest Developments
13.6 AbbVie, Inc
13.6.1 AbbVie, Inc Company Information
13.6.2 AbbVie, Inc Graves Disease Treatment Product Portfolios and Specifications
13.6.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AbbVie, Inc Main Business Overview
13.6.5 AbbVie, Inc Latest Developments
13.7 Mylan N.V
13.7.1 Mylan N.V Company Information
13.7.2 Mylan N.V Graves Disease Treatment Product Portfolios and Specifications
13.7.3 Mylan N.V Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mylan N.V Main Business Overview
13.7.5 Mylan N.V Latest Developments
13.8 Allergan, plc
13.8.1 Allergan, plc Company Information
13.8.2 Allergan, plc Graves Disease Treatment Product Portfolios and Specifications
13.8.3 Allergan, plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Allergan, plc Main Business Overview
13.8.5 Allergan, plc Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Graves Disease Treatment Product Portfolios and Specifications
13.9.3 Novartis AG Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Apitope
13.10.1 Apitope Company Information
13.10.2 Apitope Graves Disease Treatment Product Portfolios and Specifications
13.10.3 Apitope Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Apitope Main Business Overview
13.10.5 Apitope Latest Developments
13.11 Amgen INC.
13.11.1 Amgen INC. Company Information
13.11.2 Amgen INC. Graves Disease Treatment Product Portfolios and Specifications
13.11.3 Amgen INC. Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Amgen INC. Main Business Overview
13.11.5 Amgen INC. Latest Developments
13.12 Sun Pharmaceuticals Industries LTD
13.12.1 Sun Pharmaceuticals Industries LTD Company Information
13.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolios and Specifications
13.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sun Pharmaceuticals Industries LTD Main Business Overview
13.12.5 Sun Pharmaceuticals Industries LTD Latest Developments
13.13 Immunovant Inc
13.13.1 Immunovant Inc Company Information
13.13.2 Immunovant Inc Graves Disease Treatment Product Portfolios and Specifications
13.13.3 Immunovant Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Immunovant Inc Main Business Overview
13.13.5 Immunovant Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Graves Disease Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Graves Disease Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Anti-Thyroid Medication
Table 4. Major Players of Radioactive Iodine Therapy
Table 5. Global Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Graves Disease Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Graves Disease Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Graves Disease Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Graves Disease Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Graves Disease Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Graves Disease Treatment Revenue by Application (2018-2023)
Table 13. Global Graves Disease Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Graves Disease Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Graves Disease Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Graves Disease Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Graves Disease Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Graves Disease Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Graves Disease Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Graves Disease Treatment Producing Area Distribution and Sales Area
Table 21. Players Graves Disease Treatment Products Offered
Table 22. Graves Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Graves Disease Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Graves Disease Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Graves Disease Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Graves Disease Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Graves Disease Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Graves Disease Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Graves Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Graves Disease Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Graves Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Graves Disease Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Graves Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Graves Disease Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Graves Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Graves Disease Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Graves Disease Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Graves Disease Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Graves Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Graves Disease Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Graves Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Graves Disease Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Graves Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Graves Disease Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Graves Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Graves Disease Treatment
Table 58. Key Market Challenges & Risks of Graves Disease Treatment
Table 59. Key Industry Trends of Graves Disease Treatment
Table 60. Graves Disease Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Graves Disease Treatment Distributors List
Table 63. Graves Disease Treatment Customer List
Table 64. Global Graves Disease Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Graves Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Graves Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Graves Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Graves Disease Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Graves Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Graves Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Graves Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Graves Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Graves Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Graves Disease Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Graves Disease Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Graves Disease Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Graves Disease Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Graves Disease Treatment Product Portfolios and Specifications
Table 80. Abbott Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. GlaxoSmithKline plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline plc Graves Disease Treatment Product Portfolios and Specifications
Table 85. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline plc Main Business
Table 87. GlaxoSmithKline plc Latest Developments
Table 88. Merck & Co Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co Graves Disease Treatment Product Portfolios and Specifications
Table 90. Merck & Co Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Merck & Co Main Business
Table 92. Merck & Co Latest Developments
Table 93. Pfizer, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer, Inc Graves Disease Treatment Product Portfolios and Specifications
Table 95. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer, Inc Main Business
Table 97. Pfizer, Inc Latest Developments
Table 98. RLC LABS Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. RLC LABS Graves Disease Treatment Product Portfolios and Specifications
Table 100. RLC LABS Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. RLC LABS Main Business
Table 102. RLC LABS Latest Developments
Table 103. AbbVie, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. AbbVie, Inc Graves Disease Treatment Product Portfolios and Specifications
Table 105. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. AbbVie, Inc Main Business
Table 107. AbbVie, Inc Latest Developments
Table 108. Mylan N.V Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Mylan N.V Graves Disease Treatment Product Portfolios and Specifications
Table 110. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Mylan N.V Main Business
Table 112. Mylan N.V Latest Developments
Table 113. Allergan, plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Allergan, plc Graves Disease Treatment Product Portfolios and Specifications
Table 115. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Allergan, plc Main Business
Table 117. Allergan, plc Latest Developments
Table 118. Novartis AG Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AG Graves Disease Treatment Product Portfolios and Specifications
Table 120. Novartis AG Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
Table 123. Apitope Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Apitope Graves Disease Treatment Product Portfolios and Specifications
Table 125. Apitope Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Apitope Main Business
Table 127. Apitope Latest Developments
Table 128. Amgen INC. Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Amgen INC. Graves Disease Treatment Product Portfolios and Specifications
Table 130. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Amgen INC. Main Business
Table 132. Amgen INC. Latest Developments
Table 133. Sun Pharmaceuticals Industries LTD Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolios and Specifications
Table 135. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Sun Pharmaceuticals Industries LTD Main Business
Table 137. Sun Pharmaceuticals Industries LTD Latest Developments
Table 138. Immunovant Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 139. Immunovant Inc Graves Disease Treatment Product Portfolios and Specifications
Table 140. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Immunovant Inc Main Business
Table 142. Immunovant Inc Latest Developments
Table 1. Graves Disease Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Graves Disease Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Anti-Thyroid Medication
Table 4. Major Players of Radioactive Iodine Therapy
Table 5. Global Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Graves Disease Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Graves Disease Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Graves Disease Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Graves Disease Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Graves Disease Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Graves Disease Treatment Revenue by Application (2018-2023)
Table 13. Global Graves Disease Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Graves Disease Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Graves Disease Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Graves Disease Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Graves Disease Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Graves Disease Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Graves Disease Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Graves Disease Treatment Producing Area Distribution and Sales Area
Table 21. Players Graves Disease Treatment Products Offered
Table 22. Graves Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Graves Disease Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Graves Disease Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Graves Disease Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Graves Disease Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Graves Disease Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Graves Disease Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Graves Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Graves Disease Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Graves Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Graves Disease Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Graves Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Graves Disease Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Graves Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Graves Disease Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Graves Disease Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Graves Disease Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Graves Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Graves Disease Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Graves Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Graves Disease Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Graves Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Graves Disease Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Graves Disease Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Graves Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Graves Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Graves Disease Treatment
Table 58. Key Market Challenges & Risks of Graves Disease Treatment
Table 59. Key Industry Trends of Graves Disease Treatment
Table 60. Graves Disease Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Graves Disease Treatment Distributors List
Table 63. Graves Disease Treatment Customer List
Table 64. Global Graves Disease Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Graves Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Graves Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Graves Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Graves Disease Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Graves Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Graves Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Graves Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Graves Disease Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Graves Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Graves Disease Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Graves Disease Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Graves Disease Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Graves Disease Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Graves Disease Treatment Product Portfolios and Specifications
Table 80. Abbott Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. GlaxoSmithKline plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline plc Graves Disease Treatment Product Portfolios and Specifications
Table 85. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline plc Main Business
Table 87. GlaxoSmithKline plc Latest Developments
Table 88. Merck & Co Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co Graves Disease Treatment Product Portfolios and Specifications
Table 90. Merck & Co Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Merck & Co Main Business
Table 92. Merck & Co Latest Developments
Table 93. Pfizer, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer, Inc Graves Disease Treatment Product Portfolios and Specifications
Table 95. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer, Inc Main Business
Table 97. Pfizer, Inc Latest Developments
Table 98. RLC LABS Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. RLC LABS Graves Disease Treatment Product Portfolios and Specifications
Table 100. RLC LABS Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. RLC LABS Main Business
Table 102. RLC LABS Latest Developments
Table 103. AbbVie, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. AbbVie, Inc Graves Disease Treatment Product Portfolios and Specifications
Table 105. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. AbbVie, Inc Main Business
Table 107. AbbVie, Inc Latest Developments
Table 108. Mylan N.V Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Mylan N.V Graves Disease Treatment Product Portfolios and Specifications
Table 110. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Mylan N.V Main Business
Table 112. Mylan N.V Latest Developments
Table 113. Allergan, plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Allergan, plc Graves Disease Treatment Product Portfolios and Specifications
Table 115. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Allergan, plc Main Business
Table 117. Allergan, plc Latest Developments
Table 118. Novartis AG Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AG Graves Disease Treatment Product Portfolios and Specifications
Table 120. Novartis AG Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
Table 123. Apitope Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Apitope Graves Disease Treatment Product Portfolios and Specifications
Table 125. Apitope Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Apitope Main Business
Table 127. Apitope Latest Developments
Table 128. Amgen INC. Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Amgen INC. Graves Disease Treatment Product Portfolios and Specifications
Table 130. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Amgen INC. Main Business
Table 132. Amgen INC. Latest Developments
Table 133. Sun Pharmaceuticals Industries LTD Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolios and Specifications
Table 135. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Sun Pharmaceuticals Industries LTD Main Business
Table 137. Sun Pharmaceuticals Industries LTD Latest Developments
Table 138. Immunovant Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 139. Immunovant Inc Graves Disease Treatment Product Portfolios and Specifications
Table 140. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Immunovant Inc Main Business
Table 142. Immunovant Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Graves Disease Treatment
Figure 2. Graves Disease Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Graves Disease Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Graves Disease Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Graves Disease Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Anti-Thyroid Medication
Figure 10. Product Picture of Radioactive Iodine Therapy
Figure 11. Global Graves Disease Treatment Sales Market Share by Type in 2022
Figure 12. Global Graves Disease Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Graves Disease Treatment Consumed in Hospitals Pharmacies
Figure 14. Global Graves Disease Treatment Market: Hospitals Pharmacies (2018-2023) & (K Units)
Figure 15. Graves Disease Treatment Consumed in Retail Pharmacies
Figure 16. Global Graves Disease Treatment Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Global Graves Disease Treatment Sales Market Share by Application (2022)
Figure 18. Global Graves Disease Treatment Revenue Market Share by Application in 2022
Figure 19. Graves Disease Treatment Sales Market by Company in 2022 (K Units)
Figure 20. Global Graves Disease Treatment Sales Market Share by Company in 2022
Figure 21. Graves Disease Treatment Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Graves Disease Treatment Revenue Market Share by Company in 2022
Figure 23. Global Graves Disease Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Graves Disease Treatment Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 26. Americas Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 27. APAC Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 28. APAC Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 29. Europe Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 30. Europe Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Americas Graves Disease Treatment Sales Market Share by Country in 2022
Figure 34. Americas Graves Disease Treatment Revenue Market Share by Country in 2022
Figure 35. Americas Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 36. Americas Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 37. United States Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Graves Disease Treatment Sales Market Share by Region in 2022
Figure 42. APAC Graves Disease Treatment Revenue Market Share by Regions in 2022
Figure 43. APAC Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 44. APAC Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 45. China Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Graves Disease Treatment Sales Market Share by Country in 2022
Figure 53. Europe Graves Disease Treatment Revenue Market Share by Country in 2022
Figure 54. Europe Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 55. Europe Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 56. Germany Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Graves Disease Treatment Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 65. Egypt Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Graves Disease Treatment in 2022
Figure 71. Manufacturing Process Analysis of Graves Disease Treatment
Figure 72. Industry Chain Structure of Graves Disease Treatment
Figure 73. Channels of Distribution
Figure 74. Global Graves Disease Treatment Sales Market Forecast by Region (2024-2029)
Figure 75. Global Graves Disease Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Graves Disease Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Graves Disease Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Graves Disease Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Graves Disease Treatment Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Graves Disease Treatment
Figure 2. Graves Disease Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Graves Disease Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Graves Disease Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Graves Disease Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Anti-Thyroid Medication
Figure 10. Product Picture of Radioactive Iodine Therapy
Figure 11. Global Graves Disease Treatment Sales Market Share by Type in 2022
Figure 12. Global Graves Disease Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Graves Disease Treatment Consumed in Hospitals Pharmacies
Figure 14. Global Graves Disease Treatment Market: Hospitals Pharmacies (2018-2023) & (K Units)
Figure 15. Graves Disease Treatment Consumed in Retail Pharmacies
Figure 16. Global Graves Disease Treatment Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Global Graves Disease Treatment Sales Market Share by Application (2022)
Figure 18. Global Graves Disease Treatment Revenue Market Share by Application in 2022
Figure 19. Graves Disease Treatment Sales Market by Company in 2022 (K Units)
Figure 20. Global Graves Disease Treatment Sales Market Share by Company in 2022
Figure 21. Graves Disease Treatment Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Graves Disease Treatment Revenue Market Share by Company in 2022
Figure 23. Global Graves Disease Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Graves Disease Treatment Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 26. Americas Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 27. APAC Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 28. APAC Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 29. Europe Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 30. Europe Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Graves Disease Treatment Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Graves Disease Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Americas Graves Disease Treatment Sales Market Share by Country in 2022
Figure 34. Americas Graves Disease Treatment Revenue Market Share by Country in 2022
Figure 35. Americas Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 36. Americas Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 37. United States Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Graves Disease Treatment Sales Market Share by Region in 2022
Figure 42. APAC Graves Disease Treatment Revenue Market Share by Regions in 2022
Figure 43. APAC Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 44. APAC Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 45. China Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Graves Disease Treatment Sales Market Share by Country in 2022
Figure 53. Europe Graves Disease Treatment Revenue Market Share by Country in 2022
Figure 54. Europe Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 55. Europe Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 56. Germany Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Graves Disease Treatment Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Graves Disease Treatment Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Graves Disease Treatment Sales Market Share by Application (2018-2023)
Figure 65. Egypt Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Graves Disease Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Graves Disease Treatment in 2022
Figure 71. Manufacturing Process Analysis of Graves Disease Treatment
Figure 72. Industry Chain Structure of Graves Disease Treatment
Figure 73. Channels of Distribution
Figure 74. Global Graves Disease Treatment Sales Market Forecast by Region (2024-2029)
Figure 75. Global Graves Disease Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Graves Disease Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Graves Disease Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Graves Disease Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Graves Disease Treatment Revenue Market Share Forecast by Application (2024-2029)
